| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |